TP53 and hepatocellular carcinoma: Coincidentally, the decreased p53 function is accompanied by overexpression of Bcl-xL and MCL-1, as well as a lack of response to Fas owing to the downregulation of FasL and the reduced expression of Bid in HCC associated with hepatitis B or C infections (May and May, 1999).